EMA Authorised: Clopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan) (acetylsalicylic acid;clopidogrel hydrogen sulfate) — Mylan Pharmaceuticals Limited

View source ↗

Summary

EMA authorised a fixed-dose combination of clopidogrel and acetylsalicylic acid (Viatris) for acute coronary syndrome and myocardial infarction. The marketing a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• Clopidogrel / Acetylsalicylic acid Viatris (clopidogrel hydrogen sulfate; acetylsalicylic acid)

Snippet

Status: Authorised. Therapeutic area: Acute Coronary Syndrome;Myocardial Infarction. MAH: Mylan Pharmaceuticals Limited. Decision date: 02/05/2025